Soumi Gupta, Ph.D.

Senior Director, Clinical Immunology at BioMarin Pharmaceutical

Speaker

Soumi Gupta received her Ph.D. in microbiology from University of California, Davis in 2003, where the focus of her research was aimed at furthering our understanding of the immune correlates of protection towards a successful AIDS vaccine. She pursued post-doctoral training in immunology at Chiron Corporation where she investigated the role of the mucosal immune system in conferring protective immunity to HIV. Following her post-doctoral training, she worked at Monogram Biosciences in Research, focusing on assessing genotypic and phenotypic correlates of HIV drug resistance. Soumi joined BioMarin in 2015 and as head of Clinical Immunology group at BioMarin, is responsible for direct oversight of critical immunology support to enable progression of BMRN products through its life cycle. Additionally, as part of the Translational Sciences Leadership Team, she is responsible for oversight of Early Drug Development teams and strategic guidance and review of all drug development plans across the portfolio, including anti-sense oligonucleotide therapy for DMD.